Literature DB >> 21937682

RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.

Anthony J Saporita1, Hsiang-Chun Chang, Crystal L Winkeler, Anthony J Apicelli, Raleigh D Kladney, Jianbo Wang, R Reid Townsend, Loren S Michel, Jason D Weber.   

Abstract

The p19ARF tumor suppressor limits ribosome biogenesis and responds to hyperproliferative signals to activate the p53 checkpoint response. Although its activation of p53 has been well characterized, the role of ARF in restraining nucleolar ribosome production is poorly understood. Here we report the use of a mass spectroscopic analysis to identify protein changes within the nucleoli of Arf-deficient mouse cells. Through this approach, we discovered that ARF limited the nucleolar localization of the RNA helicase DDX5, which promotes the synthesis and maturation of rRNA, ultimately increasing ribosome output and proliferation. ARF inhibited the interaction between DDX5 and nucleophosmin (NPM), preventing association of DDX5 with the rDNA promoter and nuclear pre-ribosomes. In addition, Arf-deficient cells transformed by oncogenic RasV12 were addicted to DDX5, because reduction of DDX5 was sufficient to impair RasV12-driven colony formation in soft agar and tumor growth in mice. Taken together, our findings indicate that DDX5 is a key p53-independent target of the ARF tumor suppressor and is a novel non-oncogene participant in ribosome biogenesis. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937682      PMCID: PMC3206203          DOI: 10.1158/0008-5472.CAN-11-1472

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  Directed proteomic analysis of the human nucleolus.

Authors:  Jens S Andersen; Carol E Lyon; Archa H Fox; Anthony K L Leung; Yun Wah Lam; Hanno Steen; Matthias Mann; Angus I Lamond
Journal:  Curr Biol       Date:  2002-01-08       Impact factor: 10.834

2.  UBF binding in vivo is not restricted to regulatory sequences within the vertebrate ribosomal DNA repeat.

Authors:  Audrey C O'Sullivan; Gareth J Sullivan; Brian McStay
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  p53-independent functions of the p19(ARF) tumor suppressor.

Authors:  J D Weber; J R Jeffers; J E Rehg; D H Randle; G Lozano; M F Roussel; C J Sherr; G P Zambetti
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

4.  Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.

Authors:  Masataka Sugimoto; Mei-Ling Kuo; Martine F Roussel; Charles J Sherr
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

5.  Nucleolar Arf sequesters Mdm2 and activates p53.

Authors:  J D Weber; L J Taylor; M F Roussel; C J Sherr; D Bar-Sagi
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

6.  Physical and functional interaction of the p14ARF tumor suppressor with ribosomes.

Authors:  Helen Rizos; Heather A McKenzie; Ana Luisa Ayub; Sarah Woodruff; Therese M Becker; Lyndee L Scurr; Joachim Stahl; Richard F Kefford
Journal:  J Biol Chem       Date:  2006-10-11       Impact factor: 5.157

7.  TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation.

Authors:  Corey L Pelletier; Leonard B Maggi; Suzanne N Brady; Danielle K Scheidenhelm; David H Gutmann; Jason D Weber
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I.

Authors:  Frédéric Lessard; Françoise Morin; Stacey Ivanchuk; Frédéric Langlois; Victor Stefanovsky; James Rutka; Tom Moss
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

Review 9.  Does the ribosome translate cancer?

Authors:  Davide Ruggero; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

10.  Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.

Authors:  David Bertwistle; Masataka Sugimoto; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

View more
  30 in total

Review 1.  P68 RNA helicase as a molecular target for cancer therapy.

Authors:  Ting-Yu Dai; Liu Cao; Zi-Chen Yang; Ya-Shu Li; Li Tan; Xin-Ze Ran; Chun-Meng Shi
Journal:  J Exp Clin Cancer Res       Date:  2014-08-24

2.  The expression of RNA helicase DDX5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells.

Authors:  Ramiro José González-Duarte; Verna Cázares-Ordoñez; Lorenza Díaz; Víctor Ortíz; Fernando Larrea; Euclides Avila
Journal:  Mol Cell Biochem       Date:  2015-08-28       Impact factor: 3.396

Review 3.  The DDX5/Dbp2 subfamily of DEAD-box RNA helicases.

Authors:  Zheng Xing; Wai Kit Ma; Elizabeth J Tran
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-12-02       Impact factor: 9.957

Review 4.  DExD/H-box RNA helicases in ribosome biogenesis.

Authors:  Roman Martin; Annika U Straub; Carmen Doebele; Markus T Bohnsack
Journal:  RNA Biol       Date:  2012-08-24       Impact factor: 4.652

5.  Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.

Authors:  X Meng; N R Carlson; J Dong; Y Zhang
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

6.  Structural polymorphism in the N-terminal oligomerization domain of NPM1.

Authors:  Diana M Mitrea; Christy R Grace; Marija Buljan; Mi-Kyung Yun; Nicholas J Pytel; John Satumba; Amanda Nourse; Cheon-Gil Park; M Madan Babu; Stephen W White; Richard W Kriwacki
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

7.  Involvement of the miR-462/731 cluster in hypoxia response in Megalobrama amblycephala.

Authors:  Cui-Hong Huang; Nan Chen; Chun-Xiao Huang; Bao Zhang; Meng Wu; Lei He; Hong Liu; Rong Tang; Wei-Min Wang; Huan-Ling Wang
Journal:  Fish Physiol Biochem       Date:  2017-03-09       Impact factor: 2.794

8.  Down-regulated expression of NPM1 in IMS-M2 cell line by (-)-epigallocatechin-3-gallate.

Authors:  Hoang Thanh Chi; Bui Thi Kim Ly; Hoang Anh Vu; Yuko Sato; Phu Chi Dung; Phan Thi Xinh
Journal:  Asian Pac J Trop Biomed       Date:  2014-07

Review 9.  Revisiting the nucleolus: from marker to dynamic integrator of cancer signaling.

Authors:  Davide Ruggero
Journal:  Sci Signal       Date:  2012-09-11       Impact factor: 8.192

10.  Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5.

Authors:  Anthony Mazurek; Youngkyu Park; Cornelius Miething; John E Wilkinson; Jesse Gillis; Scott W Lowe; Christopher R Vakoc; Bruce Stillman
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.